AU2003239025A1 - Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd - Google Patents

Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd

Info

Publication number
AU2003239025A1
AU2003239025A1 AU2003239025A AU2003239025A AU2003239025A1 AU 2003239025 A1 AU2003239025 A1 AU 2003239025A1 AU 2003239025 A AU2003239025 A AU 2003239025A AU 2003239025 A AU2003239025 A AU 2003239025A AU 2003239025 A1 AU2003239025 A1 AU 2003239025A1
Authority
AU
Australia
Prior art keywords
gerd
treatment
combination
inhibiting agent
acid secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239025A
Inventor
Anders Lehmann
Michael Wrangstadh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2003239025A1 publication Critical patent/AU2003239025A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/04—Sulfinic acids; Esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003239025A 2002-06-20 2003-06-16 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd Abandoned AU2003239025A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0201939A SE0201939D0 (en) 2002-06-20 2002-06-20 New combination
SE0201939-6 2002-06-20
PCT/SE2003/001007 WO2004000855A1 (en) 2002-06-20 2003-06-16 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd

Publications (1)

Publication Number Publication Date
AU2003239025A1 true AU2003239025A1 (en) 2004-01-06

Family

ID=20288297

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003239025A Abandoned AU2003239025A1 (en) 2002-06-20 2003-06-16 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd

Country Status (5)

Country Link
AR (1) AR040202A1 (en)
AU (1) AU2003239025A1 (en)
SE (1) SE0201939D0 (en)
TW (1) TW200400826A (en)
WO (1) WO2004000855A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077345A1 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Compounds for the treatment of gastro-esophageal reflux disease
SE0402462D0 (en) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2006071186A1 (en) * 2004-12-27 2006-07-06 Astrazeneca Ab Use of gabab receptor agonists
WO2008033572A1 (en) 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
WO2009014490A1 (en) * 2007-07-25 2009-01-29 Astrazeneca Ab Combination of (3-amino-2-fluoropropyl)phosphinic acid and omeprazole for treating tlesr, gerd, and nerd

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (en) * 1996-09-18 1996-09-18 Astra Ab Medical use
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9904508D0 (en) * 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904507D0 (en) * 1999-12-09 1999-12-09 Astra Ab New compounds

Also Published As

Publication number Publication date
TW200400826A (en) 2004-01-16
WO2004000855A1 (en) 2003-12-31
AR040202A1 (en) 2005-03-16
SE0201939D0 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
ZA200501913B (en) New compounds for the inhibition of rotamases and use thereof
IL160630A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
PL370275A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
HK1073313A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
EP1538907A4 (en) Inhibitors of ftsz and uses thereof
HRP20040906B1 (en) Bisphosphonic acid for the treatment and prevention of ostreoporosis
EP1569917A4 (en) Pyrazine-based tubulin inhibitors
WO2001085201A3 (en) Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
GB0202254D0 (en) Prevention of scarring
HUP0402421A3 (en) Composition inhibiting matrix-metalloproteinases for the treatment of neoplastic diseases
AU2003233426A1 (en) Corrosion inhibitor
AU2003237739A1 (en) Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
WO2002003978A3 (en) A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES
AU2003239025A1 (en) Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd
AU2003216322A1 (en) Inhibitors of tubulin polymerization
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
IL147363A0 (en) Ppar delta inhibitor for the treatment of cardiovascular diseases
AU2003258941A1 (en) Metalloproteinase inhibitors and intermediates for preparation thereof
AU2003256323A1 (en) Sos1 inhibitors
AU2003297363A1 (en) Use of cathepsin k inhibitors for the treatment of glaucoma
AU2003300551A8 (en) Compounds for the inhibition of non-proteolytic enzymes
GB0202187D0 (en) "Inhibitors"
AU2002305868A1 (en) Inhibitors of reggamma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase